| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a933a0dd561e3e50b278738704d5c6e6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_18d92c46f60af8af24e262b67381d7eb |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5256
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-14022
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-14021
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-14043 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-701 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-00 |
| filingDate |
2006-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_80d06e901f5ef94d14a35d21cd114b84
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f4e26132bd50dceef78ed6abd99b9c36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b33491cab453a8d15480376adfbc635a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1aa04e7317068b16ac695b609f01c782
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_49a5c6b0f3a4446b46fbe5c84de35d1b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d8a31099fc93989d63b71582ef8dc6a2 |
| publicationDate |
2008-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1880006-A2 |
| titleOfInvention |
Primate t-lymphotropic viruses |
| abstract |
Disclosed are compositions and methods related to the isolation and identification of the novel primate T-lymphotropic viruses, HTLV-3 and HTLV-4. The diversity of HTLVs was investigated among central Africans reporting contact with NHP blood and body fluids through hunting, butchering, and keeping primate pets. Herein it is shown that this population is infected with a variety of HTLVs, including two novel retroviruses; HTLV-4 is the first member of a novel phylogenetic lineage that is distinct from all known HTLVs and STLVs; HTLV-3 falls within the genetic diversity of STLV-3, a group that has not previously been seen in humans. The present invention also relates to vectors and vaccines for use in humans against infection and disease. The invention further relates to a variety of bioassays and kits for the detection and diagnosis of infection with and diseases caused by HTLV-3 and HTLV-4 and related viruses. |
| priorityDate |
2005-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |